Prognostic Analysis and an Appropriate Antiplatelet Strategy for Patients With Percutaneous Coronary Intervention and High Bleeding Risk: Rationale and Protocol for a Multi-Center Cohort Study

Míreanna comhchosúla

• Tailoring Antithrombotic Regimens for Percutaneous Coronary Intervention Patients with High Bleeding and Ischemic Risk (TAILOR-BIRISK): Individualized Management and Genotype-Guided De-escalation
  de réir: Junyan Zhang, et al.
  Foilsithe / Cruthaithe: (2023-12-01)
• Development and Validation of a Nomogram for Predicting Long-Term Net Adverse Clinical Events in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention
  de réir: Junyan Zhang, et al.
  Foilsithe / Cruthaithe: (2025-01-01)
• Comparison of liberal versus restrictive transfusion strategies after hip surgery in patients with coronary artery disease: a post hoc analysis of the FOCUS trial
  de réir: Junyan Zhang, et al.
  Foilsithe / Cruthaithe: (2024-09-01)
• Soluble ST2 in coronary artery disease: Clinical biomarkers and treatment guidance
  de réir: Junyan Zhang, et al.
  Foilsithe / Cruthaithe: (2022-09-01)
• Antiplatelet therapy de-escalation in a patient after percutaneous coronary intervention with a high risk of bleeding
  de réir: A. A. Kassymova, et al.
  Foilsithe / Cruthaithe: (2023-06-01)